I"t<html lang="">
<head>
<meta charset="utf-8" />
<meta name="viewport" content="width=device-width, initial-scale=1.0, maximum-scale=1.0, user-scalable=no" />

</head>
<div class="wrapper row2">
  <section class="hoc container clear"> 

  <div class="sectiontitle">
      <h6 class="heading"> 大数据、人工智能和核酸药物</h6>
      <p class="nospace font-xs">陈润生院士  2023-01-04</p>
    </div>
  <div class="details">
    <div>
      <p>关键词 &nbsp;大数据 编码 基因组 核酸 转录 药物 蛋白 细胞 序列 人类基因组 核酸疫苗 人工智能 遗传密码 新冠病毒 基础研究 神经网络 深度学习 <br /> <br />
      2023年1月4日，广州实验室苗智超研究员邀请了中国科学院生物物理所的陈润生院士进行了线上学术报告“大数据、人工智能和核酸药物”, 是Guangzhou RNA Club 2023年的第一场学术报告。陈润生院士是最早从事生物学和生物信息学研究的科研人员，20多年来一直专注于生物信息学的研究，是中国早期参与人类基因组测序与拼装工作的人员之一，主持了国内生物信息学的一些早期的工作，开创性的工作。近十几年来主要从事非编码RNA 的系统发现与功能研究，发表学术论文有180多篇。陈院士是我们RNA领域的大专家。<br /><br />
大家知道，实际上RNA它的所有的发展都是来自大数据。换句话说，我们当前的生物医学的发展实际上都依赖于 90 年代初开展的以破译人的一串密码为代表的基因组研究。从此整个的大数据就进入了生物医学领域，带动了越来越多的深刻的变化。当然我们知道现在组学大数据跟医学的结合，就导致了整个医学的精准医学的出现。所以大数据是在促进整个社会医学变革的，一个原始的动力。<br /><br />
什么是大数据？<br />
陈院士将数据比做一串密码，人的一串遗传密码有 4*3* 10^9，如果以A4纸显示每个人的遗传密码，那就可以形成一百万页。大数据本身庞大的数据量和背后隐藏的深刻的生物学含义迎来了生物医学的变革。图1展示的仅仅只是一段。<br /><br />

      A ribozyme has recently been selected that can catalyse a methyl transfer reaction using O6-methylguanine as donor. With Huang Lin’s lab have solved the crystal structure of this ribozyme at a resolution of 2.3 Å, showing how the RNA folds to generate a very specific binding site for the methyl donor substrate. The structure immediately suggests a catalytic mechanism, involving a combination of proximity and orientation, and nucleobase-mediated general acid catalysis. The mechanism is supported by the pH dependence of the rate of catalysis together with atomic mutagenesis and quantum mechanical calculation. This small chemical machine employs a relatively sophisticated catalytic mechanism, broadening the range of known RNA-catalysed chemistry. This lends new support to the RNA world hypothesis.<br />
      Going still further, how could RNA overcome its relative chemical simplicity and expand its catalytic repertoire? The RNA world would have required a much broader range of RNA catalyzed chemistry, including “difficult” reactions like making C-C bonds. Modern protein enzymes achieve this by using co-enzymes, and perhaps RNA could do the same. RNA is a superb receptor for small molecules, as exemplified by the riboswitches. A significant number of these bind coenzymes, including SAM, TPP, NAD+ and FMN, and it’s not a big leap to imagine that the riboswitch might have evolved from an ancient ribozyme, or might be converted into a novel ribozyme. 
      </p>
      <table><tr>
      <td><img src="http://localhost:4000/images/newspic/David220819-1.png" alt="drawing" style="height:300px;display:block;margin:0 auto;" /></td>
      <td><img src="http://localhost:4000/images/newspic/David220819-2.png" alt="drawing" style="height:300px;display:block;margin:0 auto;" /></td>
      </tr></table>
      <p class="nospace font-xs">Deng et al.Structure and mechanism of a methyl transferase ribozyme Nature Chem Biol 18, 556–564 (2022)</p>
      
  </div>
</div>
  <div class="details">
    <br /><br /><br />
    <h7 class="heading"> 个人简介</h7>
    <p>David Lilley教授，英国皇家学会院士（Fellows of the Royal Society）、英国皇家化学学会会士（Fellow of the Royal Society of Chemistry），爱丁堡皇家学会会士（Fellow of the Royal Society of Edinburgh），欧洲分子生物学组织院士（Fellow of EMBO）。英国邓迪大学（University of Dundee）分子生物学教授，担任癌症研究所核酸结构研究组主任。曾获英国皇家化学学会跨学科奖、RNA和核酸化学奖等多个奖项。Lilley教授是核酸结构与功能领域的权威专家，历任Nucleic Acids Research、RNA等杂志编委，在Nature、Science、Cell等国际权威杂志上发表研究论文过400篇，目前被引次数28692次，高引用次数指数（h-index）93。主要研究RNA结构、ribozyme的结构和功能、DNA损伤修复等重要生命科学问题。<br />
    Royal Society of Chemistry Khorana Prize (2016)<br />
    RNA Society Lifetime Service Award (2015)<br />
    Royal Society of Chemistry, Interdisciplinary Award (2006)<br />
   RNA and Ribozyme Chemistry Award of The Royal Society of Chemistry (2002)</p>
  </div>

  </section>
  </div>

<html>
</html></html>
:ET